{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:40:47Z","timestamp":1784025647771,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["SBGJ202003012"],"award-info":[{"award-number":["SBGJ202003012"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["192102310053"],"award-info":[{"award-number":["192102310053"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["202102310053"],"award-info":[{"award-number":["202102310053"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.intimp.2022.109182","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T19:01:47Z","timestamp":1662058907000},"page":"109182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["All-trans retinoic acid enhanced the antileukemic efficacy of ABT-199 in acute myeloid leukemia by downregulating the expression of S100A8"],"prefix":"10.1016","volume":"112","author":[{"given":"Dongbei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109182_b0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41408-020-00388-x","article-title":"Venetoclax-based chemotherapy in acute and chronic myeloid neoplasms: literature survey and practice points","volume":"10","author":"Gangat","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.intimp.2022.109182_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2022.109182_b0015","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1200\/JCO.20.03736","article-title":"Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed and relapsed or refractory acute myeloid leukemia","volume":"39","author":"DiNardo","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2022.109182_b0020","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.2020006785","article-title":"BCL2 and MCL1 inhibitors for hematologic malignancies","volume":"138","author":"Roberts","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2022.109182_b0025","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.intimp.2022.109182_b0030","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/cancers13061292","article-title":"Targeting BCL-2 in cancer: advances, challenges, and perspectives","volume":"13","author":"Hafezi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2022.109182_b0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood.2019003988","article-title":"Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML","volume":"135","author":"DiNardo","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2022.109182_b0040","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/s41375-019-0504-y","article-title":"Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML","volume":"33","author":"Karjalainen","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2022.109182_b0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1101\/gad.182980.111","article-title":"Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia","volume":"26","author":"Glaser","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.intimp.2022.109182_b0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/hon.2707","article-title":"Increased S100A8 expression in bone marrow plasma by monocytic cells from acute myeloid leukemia patients","volume":"38","author":"Mondet","year":"2020","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.intimp.2022.109182_b0055","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1182\/blood-2016-09-738005","article-title":"S100A9 induces differentiation of acute myeloid leukemia cells through TLR4","volume":"129","author":"Laouedj","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2022.109182_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110156","article-title":"Roles of S100 family members in drug resistance in tumors: status and prospects","volume":"127","author":"Hua","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.intimp.2022.109182_b0065","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3390\/molecules26051323","article-title":"Pathogenic roles of S100A8 and S100A9 proteins in acute myeloid and lymphoid leukemia: clinical and therapeutic impacts","volume":"26","author":"Mondet","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2022.109182_b0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018027885","article-title":"Autophagy is required to regulate mitochondria renewal, cell attachment, and all-trans-retinoic acid-induced differentiation in NB4 acute promyelocytic leukemia cells","volume":"38","author":"Tekedereli","year":"2019","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.intimp.2022.109182_b0075","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1158\/1078-0432.CCR-15-0663","article-title":"Sorafenib inhibition of Mcl-1 accelerates ATRA-induced apoptosis in differentiation-responsive AML cells","volume":"22","author":"Wang","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2022.109182_b0080","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1080\/10428194.2019.1613540","article-title":"Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all","volume":"60","author":"Stahl","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.intimp.2022.109182_b0085","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/blood.V97.1.264","article-title":"Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo","volume":"97","author":"Jing","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2022.109182_b0090","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood.V90.9.3345","article-title":"Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR","volume":"90","author":"Monczak","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2022.109182_b0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2018.05.038","article-title":"Formononetin-induced oxidative stress abrogates the activation of STAT3\/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model","volume":"431","author":"Kim","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2022.109182_b0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.intimp.2022.109182_b0105","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/sj.onc.1207523","article-title":"Toxic proteins released from mitochondria in cell death","volume":"23","author":"Saelens","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2022.109182_b0110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2022.109182_b0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","article-title":"Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia","volume":"4","author":"Pan","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2022.109182_b0120","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1111\/bjh.18061","article-title":"H, Venetoclax for arsenic-resistant acute promyelocytic leukaemia","volume":"197","author":"Wang","year":"2022","journal-title":"Brit. J. Haematol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109182_b0125","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00277-022-04823-w","article-title":"Central nervous system relapse of acute promyelocytic leukemia treated by oral Venetoclax with Azacitidine achieved complete remission","volume":"101","author":"Li","year":"2022","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109182_b0130","doi-asserted-by":"crossref","first-page":"e1593","DOI":"10.1038\/cddis.2014.525","article-title":"MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies","volume":"6","author":"Choudhary","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2022.109182_b0135","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7150\/ijms.37833","article-title":"Suppressive effects of S100A8 and S100A9 on neutrophil apoptosis by cytokine release of human bronchial epithelial cells in asthma","volume":"17","author":"Da Kim","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.intimp.2022.109182_b0140","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.fertnstert.2011.01.155","article-title":"All-trans-retinoic acid mediates changes in PI3K and retinoic acid signaling proteins of leiomyomas","volume":"95","author":"Ben-Sasson","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.intimp.2022.109182_b0145","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/onc.2008.313","article-title":"PI3K\/Akt: getting it right matters","volume":"27","author":"Franke","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.intimp.2022.109182_b0150","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4161\/cc.2.4.433","article-title":"Multiple roles of the PI3K\/PKB (Akt) pathway in cell cycle progression","volume":"2","author":"Liang","year":"2003","journal-title":"Cell Cycle"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692200666X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692200666X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:48:05Z","timestamp":1761587285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692200666X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":30,"alternative-id":["S156757692200666X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109182","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"All-trans retinoic acid enhanced the antileukemic efficacy of ABT-199 in acute myeloid leukemia by downregulating the expression of S100A8","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109182"}}